Home › NDC Lookup › RxCUI directory › RxCUI 1483574

Docusate sodium 100 MG Oral Tablet [DOK] — RxCUI 1483574

RxNorm drug concept · Semantic branded drug
RxCUI 1483574 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1483574
Official nameDocusate sodium 100 MG Oral Tablet [DOK]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDOK 100 MG Oral Tablet; DOSS Sodium 100 MG Oral Tablet [DOK]
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)70,892 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Docusate sodium 100 MG Oral Tablet [DOK] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Docusate sodium 100 MG Oral Tablet [DOK] RxCUI 1483574

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Docusate 82003
    • Docusate sodium 71722
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • DOK 216344
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Docusate Oral Tablet 371949
    • Docusate sodium Oral Tablet 2648675
    • Docusate Oral Product 1160200
    • Docusate Pill 1160202
    • Docusate sodium Oral Product 2661151
    • Docusate sodium Pill 2663394
    • Docusate Oral Tablet [DOK] 1483573
    • Docusate sodium Oral Tablet [DOK] 2657772
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Docusate sodium 100 MG Oral Tablet SCD · 1099279
  • Docusate sodium 100 MG SCDC · 1099278
  • Docusate Oral Tablet SCDF · 371949
  • Docusate sodium Oral Tablet SCDFP · 2648675
  • Docusate Oral Product SCDG · 1160200
  • Docusate Pill SCDG · 1160202
  • Docusate sodium Oral Product SCDGP · 2661151
  • Docusate sodium Pill SCDGP · 2663394

Brand-Name Concepts

  • Docusate sodium 100 MG [DOK] SBDC · 1483567
  • Docusate Oral Tablet [DOK] SBDF · 1483573
  • Docusate sodium Oral Tablet [DOK] SBDFP · 2657772
  • DOK Oral Product SBDG · 1483569
  • DOK Pill SBDG · 1483570
  • DOK BN · 216344

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1483574 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00904-6750-60 100 TABLET in 1 BOTTLE (0904-6750-60) DOK MAJOR PHARMACEUTICALS 2018-06-01
Observed labelers: MAJOR PHARMACEUTICALS (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.0385
Range $0.0385–$0.0385 · middle 50% $0.0385–$0.0385 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.